Bronchial Fistula: Rare Complication of Treatment with Anlotinib

Bronchial Fistula: Rare Complication of Treatment with Anlotinib

Background and objective Anlotinib is a newly developed small molecule multiple receptor tyrosine kinase (RTK) inhibitor that was approved for the treatment of patients with lung cancer in China. We aim to report 3 cases of rare complication of anlotinib-bronchial fistula (BF) during the treatment o...

Full description

Bibliographic Details
Main Authors: Pengbo DENG, Chengping HU, Yuanyuan LI, Liming CAO, Huaping YANG, Min LI, Jian AN, Juan JIANG, Qihua GU
Format: Article
Language:zho
Published: Chinese Anti-Cancer Association; Chinese Antituberculosis Association 2020-10-01
Series:Chinese Journal of Lung Cancer
Subjects:
anlotinib
lung neoplasms
bronchial fistula
broncho-pericardial fistula
broncho-pleural fistula
esophago-tracheobronchial fistula
Online Access:http://dx.doi.org/10.3779/j.issn.1009-3419.2020.102.40

Internet

http://dx.doi.org/10.3779/j.issn.1009-3419.2020.102.40

Similar Items